Who
Adam Taich
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, 10x Genomics; Interim CEO, SomaLogic.
In numbers
- Trades disclosed
- 35
- Buys
- 0
- Sells
- 9
- Bought
- $0
- Sold
- $9.8M
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 2 Mar 2023
- Last trade
- 9 Sep 2026
- Last filed
- 11 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Sep 2026filed 11 Sep 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $77K1,206 at $63.68 | filing |
| 9 Sep 2026filed 11 Sep 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $2.0M31,428 at $64.31 | filing |
| 9 Sep 2026filed 11 Sep 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $898K13,754 at $65.26 | filing |
| 9 Sep 2026filed 11 Sep 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $77K1,206 at $63.68 | filing |
| 9 Sep 2026filed 11 Sep 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $2.0M31,428 at $64.31 | filing |
| 9 Sep 2026filed 11 Sep 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $898K13,754 at $65.26 | filing |
| 24 Aug 2026filed 26 Aug 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $1.1M17,166 at $63.02 | filing |
| 24 Aug 2026filed 26 Aug 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $1.1M17,166 at $63.02 | filing |
| 22 May 2026filed 27 May 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $369K15,098 at $24.44 | filing |
| 22 May 2026filed 27 May 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $369K15,098 at $24.44 | filing |
| 26 Feb 2026filed 2 Mar 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Code A | —106,579 at $0.00 | filing |
| 26 Feb 2026filed 2 Mar 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Code A | —106,579 at $0.00 | filing |
| 23 Feb 2026filed 25 Feb 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $167K8,968 at $18.58 | filing |
| 23 Feb 2026filed 25 Feb 2026 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $167K8,968 at $18.58 | filing |
| 24 Nov 2025filed 25 Nov 2025 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $226K11,888 at $19.00 | filing |
| 22 Aug 2025filed 26 Aug 2025 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $308K22,315 at $13.79 | filing |
| 22 May 2025filed 27 May 2025 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $34K4,044 at $8.30 | filing |
| 17 Mar 2025filed 19 Mar 2025 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Code A | —133,928 at $0.00 | filing |
| 23 Oct 2024filed 19 Mar 2025 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Code A | —201,704 at $0.00 | filing |
| 5 Jan 2024filed 9 Jan 2024 | SomaLogicoption or derivative | SEC FORM 4 Code D | —185,812 | filing |
News
10x Genomics (NASDAQ:TXG) CFO Adam Taich Sells 46,388 Shares of Stockdailypolitical.com · 12 Sep 20267,724 Shares in 10x Genomics $TXG Bought by QP Wealth Management LLCTXG · dailypolitical.com · 21 Oct 2026
1 headline in the last 90 days name Adam Taich; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.